30
Participants
Start Date
January 31, 1997
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Taxotere
Cisplatin
5-Fluorouracil
Leucovorin
G-CSF
Ciprofloxacin
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Sanofi
INDUSTRY
Dana-Farber Cancer Institute
OTHER